Edward V. Loftus Jr., MD

Treatment options for patients with inflammatory bowel disease — particularly in the anti-interleukin-23 space — have been emerging so quickly that information is constantly at risk of becoming outdated.

The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous induction options for the treatment of moderately to severely active Crohn’s disease, Johnson & Johnson reported.

In a Healio video exclusive, Edward V. Loftus Jr., MD, discusses the looming threat of gastroenterology workforce shortage, alongside insights from a roundtable of ACG presidents on how we might still avoid it.

This month’s Healio Gastroenterology Exclusive highlights a problem that we as physicians “feel” either directly or indirectly nearly every day — labor shortages.

In this Healio video, Edward V. Loftus Jr., MD, previews this month’s Healio Exclusive, in which experts tout the positive attributes of Janus kinase inhibitors for inflammatory bowel disease and discuss their role in the treatment landscape.

This month’s Healio Exclusive highlights the efficacy of Janus kinase inhibitors in the management of ulcerative colitis and Crohn’s disease.

In a Healio video exclusive, Edward V. Loftus Jr., MD, noted that the booming popularity in glucagon-like peptide-1 agonists have spurred an interspecialty “dilemma” regarding aspiration risks in the endoscopy suite.

In a Healio video exclusive, Edward V. Loftus Jr., MD, warned that, despite being the smallest virus capable of causing human disease, hepatitis delta virus holds an outsized global impact as the most severe form of viral hepatitis.

In a Healio video exclusive, Edward V. Loftus Jr., MD, noted that, despite the boom in glucagon-like peptide-1 agonists for diabetes and weight loss, its role in the treatment of liver disease is still up for debate.

In a Healio video exclusive, Edward V. Loftus Jr., MD, highlighted that the first step in building an LGBTQ-friendly gastroenterology practice starts with “just normalizing it.”